NATCO Pharma to consider Q4, FY19 results on May 27, 2019
21/05/2019 17:04
NATCO Pharma Limited said in a filing to BSE that the meeting of the board of directors is scheduled to be held on May 27, 2019, to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2019.